Suchergebnisse - "WANG MANLI"

PubPharm (408)

61

APPLICATION OF NITAZOXANIDE AND ACTIVE FORM THEREOF, TIZOXANIDE, IN TREATMENT OF SARS-COV-2 INFECTION

enthalten in: Europäisches Patentamt | 2023

von ZHONG WU | XIAO GENGFU | HU ZHIHONG | +7

62

APPLICATION OF NITAZOXANIDE AND ACTIVE FORM THEREOF, TIZOXANIDE, IN TREATMENT OF SARS-COV-2 INFECTION

enthalten in: Europäisches Patentamt | 2023

von ZHONG WU | XIAO GENGFU | HU ZHIHONG | +7

63

APPLICATION OF RITONAVIR IN TREATING SARS-COV-2 INFECTION

enthalten in: Europäisches Patentamt | 2023

von ZHONG WU | HU ZHIHONG | XIAO GENGFU | +6

64

APPLICATION OF RITONAVIR IN TREATING SARS-COV-2 INFECTION

enthalten in: Europäisches Patentamt | 2023

von ZHONG WU | HU ZHIHONG | XIAO GENGFU | +6

65

Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro

enthalten in: Viruses | 2023

von Wang, X. | Burdzhiev, N. | Hu, H. | +5

66

Atlas of interactions between SARS-CoV-2 macromolecules and host proteins

enthalten in: Cell insight | 2023

von Li, G. | Tang, Z. | Fan, W. | +6

67

APPLICATION OF DIMETHYL BERBAMINE COMPOUND IN INHIBITION OF SARS-COV-2

enthalten in: Europäisches Patentamt | 2023

von ZHONG WU | QIN CHENGFENG | ZHOU XINBO | +11

68

Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation

enthalten in: Endocrine-related cancer | 2023

von Hu, C. | Wang, M. | Hu, M. | +6

69

Antiviral effects and tissue exposure of tetrandrine against SARS-CoV-2 infection and COVID-19

enthalten in: MedComm | 2023

von Liu, J. | Wang, F. | Wang, X. | +16

70

Influence of Enzymes on the In Vitro Degradation Behavior of Pure Zn in Simulated Gastric and Intestinal Fluids

enthalten in: ACS omega | 2023

von Wang, M. | Yang, L. | Zhu, X. | +2